Certificate number:RU.77.99.11.003.Е.003885.09.17
Date of registration and renewal:01.09.2017
Dosage form: & nbspTablets, film-coated, weighing 1430 mg ± 5%
Classification "Composition" & nbsp Supplements - vitamins, vitamin-like substances and coenzymes
Classification "Clinical" & nbsp Supplements containing zinc, copper, manganese Supplements containing iodine Supplements containing chromium Supplements containing selenium
Composition: & nbspCalcium carbonate, calcium hydrophosphate, magnesium oxide, potassium chloride, vitamin C (L-ascorbic acid), vitamin E (D-alpha-tocopherol acetate), microcrystalline cellulose, stearic acid, silicon dioxide stabilizer, tablet shell (hydroxypropylmethylcellulose, titanium dioxide, polydextrose, talc, maltodextrin, medium-chain triglycerides), iron fumarate, niacinamide, zinc oxide, crocarmellose sodium, vitamin A acetate, calcium-D-pantothenate, magnesium stearic acid, chromium chloride, manganese sulfate monohydrate, vit min D (cholecalciferol), vitamin B6 (pyridoxine hydrochloride), D-biotin, copper oxide, folic acid, vitamin B1 (thiamine hydrochloride), potassium iodide, vitamin B2 (riboflavin), sodium borate, sodium molybdate, sodium metavanadate, vitamin K1 , sodium selenate, vitamin B12 (cyanocobalamin), beta-carotene.
Scope: & nbspFor the realization of the supplementary source of vitamins A, D3, E, C, B1, B2, B6, B12, PP (niacinamide), B5 (pantothenic acid), vitamin B,folic acid, biotin, minerals: magnesium, iron, zinc, manganese, copper, iodine, selenium, chromium, molybdenum, vanadium containing calcium.
Suggested Usage: & nbspAdults take 1 tablet a day with meals. Duration of admission is 2-3 weeks. If necessary, the reception can be repeated in a month.
Contraindications:Individual intolerance to the components of the product, pregnancy, breast-feeding. Before use, it is recommended to consult a doctor. Persons with thyroid disease should consult an endocrinologist.
Shelf life:2 years.
Storage conditions:Store in a place inaccessible to children at a temperature of 15 ° C to 25 ° C and at a relative humidity of not more than 60%.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.003510.08.17 of 08/08/2017, the expert opinion of the FBUC of the Federal Service for Supervision of Consumer Rights Protection of the Russian Federation No. 10-2FTS / 2738 of July 21, 2017
Recipient:Takeda Pharmaceuticals, LLCTakeda Pharmaceuticals, LLC Russian Federation
Information update date: & nbsp10.12.2017
Instructions
Up